Merck & Co., Inc. (MRK)
| Market Cap | 317.26B |
| Revenue (ttm) | 61.40B |
| Net Income (ttm) | 2.31B |
| Shares Out | 2.53B |
| EPS (ttm) | 0.90 |
| PE Ratio | 139.18 |
| Forward PE | 13.81 |
| Dividend | $3.08 (2.46%) |
| Ex-Dividend Date | Sep 16, 2024 |
| Volume | 4,757,882 |
| Open | 127.24 |
| Previous Close | 125.85 |
| Day's Range | 125.05 - 128.73 |
| 52-Week Range | 99.14 - 134.63 |
| Beta | 0.39 |
| Analysts | Buy |
| Price Target | 135.36 (+8.06%) |
| Earnings Date | Jul 30, 2024 |
About MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M−M−R II, Variv... [Read more]
Financial Performance
In 2023, Merck & Co.'s revenue was $60.12 billion, an increase of 1.40% compared to the previous year's $59.28 billion. Earnings were $365.00 million, a decrease of -97.49%.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for MRK stock is "Buy." The 12-month stock price forecast is $135.36, which is an increase of 8.06% from the latest price.
News
Germany's Merck raises 2024 sales forecast
Germany's Merck on Friday further its forecast for the group and said it now expects net sales to be between 20.7 billion euros ($22.49 billion) and 22.1 billion euros for 2024.
Is An Earnings Beat In The Cards For Merck Stock?
Merck (NYSE: MRK) will report its Q2 2024 results on Tuesday, July 30. We expect the company to post revenue of $15.9 billion and adjusted earnings of $2.20, slightly ahead of the street estimates.
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Receives Positive EU CHMP Opinion for KEYTRUDA Plus Padcev as First-Line Treatment for Patients With Advanced Bladder Cancer.
Merck Announces Fourth-Quarter 2024 Dividend
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Fourth-Quarter 2024 Dividend.
Merck's RSV drug meets main goals of mid-to-late stage trial
Merck said on Tuesday its respiratory syncytial virus (RSV) drug met the safety and efficacy goals in a mid- to late- stage study testing it in infants.
Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK--Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational RSV Preventative Monoclonal Antibody for Infants.
Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024.
Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing
Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing
Merck Completes Acquisition of EyeBio
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Eyebiotech Limited (EyeBio). EyeBio is now ...
4 Cheap Stocks to Buy Ahead of Earnings
Cigna, Merck, Toll Brothers, Medtronic could see shares gain after proving their earnings growth remains strong.
3 buys and a bail: Merck, Abbott, Cigna, and Zoom
Gina Sanchez, chief market strategist at Lido Advisors, joins CNBC's 'The Exchange' to discuss four stocks: Merck, Abbott, Cigna, and Zoom.
Merck Animal Health Completes Acquisition of Elanco's Aqua Business
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced t...
Elanco Completes Sale of Aqua Business
Transaction concentrates Elanco's focus on significant value creation opportunities and accelerates deleveraging progress GREENFIELD, Ind. , July 9, 2024 /PRNewswire/ -- Elanco Animal Health Incorpora...
‘Crash proof' your portfolio with these 10 stocks and 3 ETFs
You don't get upset for having homeowner's insurance but your house doesn't burn down. The same principle should apply to investors who insure their stock portfolios against a crash.
N-Power Medicine Collaborates with Merck to Expand Oncologist and Patient Access to Clinical Trials
REDWOOD CITY, Calif.--(BUSINESS WIRE)--N-Power Medicine collaborates with Merck to expand oncologist and patient access to clinical trials.
Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Orion Corporation (“Orion”) today announced that notice has been provided of the mutual exer...
Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30.
Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH).
Global Bioreactors Market Forecast Report 2024-2035 with Key Players Profiles of Applikon Biotechnology, Bionet, Cytiva, Eppendorf, Merck, Sartorius, Solaris Biotech, Solida Biotech and LABAO
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material, Type of Bioprocess, Type of Biologic, and Key...
CDC'S ACIP Unanimously Recommends Merck's CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--CDC'S ACIP Unanimously Recommends Merck's CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults.
Merck Stock Is Slipping. A CDC Committee Considers Pneumococcal Vaccines.
News out of a Centers for Disease Control and Prevention meeting appeared to dim the commercial prospects of Merck's new pneumococcal vaccine.
US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
The U.S. Food and Drug Administration declined to approve Merck and Japan-based Daiichi Sankyo's lung cancer treatment, which belongs to a lucrative class of cancer therapies that work like "guided mi...
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer
BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) seeking acceler...
Healthcare: Best strategies to invest in pharma stocks
Novo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as their approval in China. While these names...
USDA Approves Merck Animal Health's NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today t...